MAbxience
Web: http://mabxience.com
Founding Year: 2013
Industries: health
Business Model: manufacturing
Business Focus: B2B
Short Description: compañía biotecnológica de desarrollo, fabricación y comercialización de productos biofarmacéuticos.
Overview: compañía biotecnológica líder a nivel mundial, con más de una década de experiencia en el desarrollo, fabricación y comercialización de productos biofarmacéuticos.
See profile on the Startup Radar madri+d platform on Dealroom:
News and Interviews
- Oct 04, 2024 Teva and mAbxience partner to develop biosimilar candidate for oncology
- May 09, 2024 Mabxience Appoints Jurgen Van Broeck As New Ceo
- May 09, 2024 mAbxience Appoints Jurgen Van Broeck as New CEO
- May 09, 2024 mAbxience Appoints Jurgen Van Broeck as New CEO
- Abr 21, 2022 Amneal Pharmaceuticals LLC partnered with mAbxience on Jan 1st 18'.
- Abr 05, 2022 Fresenius Kabi Takes Control Of mAbxience To Bolster Biosimilars
- Abr 04, 2022 Germany: Fresenius Kabi buys majority stake in mAbxience and acquires Ivenix
- Mar 31, 2022 Fresenius Kabi acquires mAbxience
- Mar 29, 2022 Cipla Medpro South Africa Ltd. partners with mAbxience
- Ene 11, 2022 Cipla Inc. partners with mAbxience
- Sep 21, 2021 SINERGIUM SISTEMAS S.L. partners with mAbxience,
- Sep 21, 2021 SINERGIUM Biotech partners with mAbxience,
- Ago 31, 2021 mAbxience, partners with Zentiva Group